Skip to main content
. 2021 Jan 4;12(1):33. doi: 10.1038/s41419-020-03306-y

Fig. 1. MiR-153-5p was identified as a candidate miRNA to promote tumor progression in patients with ccRCC.

Fig. 1

AC Volcano plots depicting differentially expressed miRNAs between ccRCC and normal tissue A, between M1 and M0 B, and between <1-year survival (1-yr) and >5-year survival (5-yr) C. D Schematic illustration displayed the overlapping of miRNAs by three volcano plots.